New Delhi, Sept. 29 -- Pharmaceutical stocks staged a strong rebound on Monday, recovering from last week's sharp decline after clarity emerged on the scope of fresh US tariffs on imported drugs.

Shares of Wockhardt rallied over 10%, leading the recovery in the sector. Bajaj Healthcare, Supriya Lifescience, Alembic Pharmaceuticals, Aster DM Healthcare, Sun Pharmaceutical Industries, Lupin, Cipla, Aarti Drugs, Zydus Lifesciences, Biocon, and others gained between 1-3%.

The Nifty Pharma index advanced over 1%, driven by key constituents such as Sun Pharma, Lupin, Cipla, Zydus Lifesciences, JB Chemicals & Pharmaceuticals, and Biocon.

The recovery in pharma stocks today comes after a steep correction on Friday, when US President Donald Tru...